Funding Rounds
Alpha-9 Theranostics

Alpha9 Theranostics October 2024 Series C Funding Round

Alpha-9 Theranostics

Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series C

Raised Amount: $127.75M

Raised Date: 2024-10-23

Investors